Inhibition of intercellular communication: An in vitro assay for detecting potential tumour promoters

A Cooper1, J Fentem, M Balls

  • 1FRAME Alternatives Laboratory, Department of Human Morphology, University of Nottingham Medical School, Nottingham NG7 2UH, UK.

Insights

This study shows that measuring inhibition of gap junctional intercellular communication (GJIC) in vitro can help distinguish chemicals with different tumor-promoting effects. This assay effectively ranked phorbol esters by potency.

Area of Science:

  • Toxicology
  • Cell Biology
  • Carcinogenesis

Background:

  • Gap junctional intercellular communication (GJIC) plays a crucial role in cellular regulation.
  • Tumor promoters are agents that enhance the development of cancer but do not initiate it.
  • Assessing tumor-promoting potential is vital for chemical safety evaluation.

Purpose of the Study:

  • To evaluate the effects of non-cytotoxic concentrations of 13 tumor promoters and irritants on GJIC.
  • To determine if in vitro GJIC inhibition assays can predict in vivo tumor-promoting potencies.
  • To assess the assay's ability to differentiate genotoxic from non-genotoxic chemicals.

Main Methods:

  • Utilized a scrape-labelling method to measure GJIC in human keratinocytes and WB 344 cells.
  • Selected 13 chemicals based on known tumor-promoting effects (skin/liver) or skin irritancy.
  • Exposed cells to non-cytotoxic concentrations of selected chemicals.

Main Results:

  • The in vitro assay successfully discriminated between genotoxic and non-genotoxic chemicals.
  • Keratinocyte cultures accurately ranked phorbol esters according to their known in vivo tumor-promoting potencies.
  • Significant inhibition of GJIC was observed for several tested chemicals.

Conclusions:

  • Measurement of GJIC inhibition in vitro is a promising method for distinguishing chemicals with varying tumor-promoting potencies.
  • This assay can serve as a valuable tool in the toxicological assessment of chemicals.
  • The findings support the use of GJIC assays for predicting in vivo carcinogenic potential.

Related Concept Videos